These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28244745)

  • 21. The Ecstasy and Agony of Assay Interference Compounds.
    Aldrich C; Bertozzi C; Georg GI; Kiessling L; Lindsley C; Liotta D; Merz KM; Schepartz A; Wang S
    ACS Infect Dis; 2017 Apr; 3(4):259-262. PubMed ID: 28244723
    [No Abstract]   [Full Text] [Related]  

  • 22. Discovery of novel inhibitors of human S-adenosylmethionine decarboxylase based on in silico high-throughput screening and a non-radioactive enzymatic assay.
    Liao C; Wang Y; Tan X; Sun L; Liu S
    Sci Rep; 2015 Jun; 5():10754. PubMed ID: 26030749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A printable hydrogel microarray for drug screening avoids false positives associated with promiscuous aggregating inhibitors.
    Mateen R; Ali MM; Hoare T
    Nat Commun; 2018 Feb; 9(1):602. PubMed ID: 29426913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apparent activity in high-throughput screening: origins of compound-dependent assay interference.
    Thorne N; Auld DS; Inglese J
    Curr Opin Chem Biol; 2010 Jun; 14(3):315-24. PubMed ID: 20417149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput analysis of in vitro cytochrome p450 inhibition samples using mass spectrometry coupled with an integrated liquid chromatography/autosampler system.
    Brown A; Bickford S; Hatsis P; Amin J; Bell L; Harriman S
    Rapid Commun Mass Spectrom; 2010 Apr; 24(8):1207-10. PubMed ID: 20301107
    [No Abstract]   [Full Text] [Related]  

  • 26. Major Improvements in Robustness and Efficiency during the Screening of Novel Enzyme Effectors by the 3-Point Kinetics Assay.
    Pinto MF; Figueiredo F; Silva A; Pombinho AR; Pereira PJB; Macedo-Ribeiro S; Rocha F; Martins PM
    SLAS Discov; 2021 Mar; 26(3):373-382. PubMed ID: 32981414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smaller is better for antibiotic discovery.
    Waldrop GL
    ACS Chem Biol; 2009 Jun; 4(6):397-9. PubMed ID: 19537754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput mass spectrometric cytochrome P450 inhibition screening.
    Lim KB; Ozbal CC; Kassel DB
    Methods Mol Biol; 2013; 987():25-50. PubMed ID: 23475665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Label-free screening assays: a strategy for finding better drug candidates.
    Lunn CA
    Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A high-throughput screen to identify novel calcineurin inhibitors.
    Margassery LM; Kennedy J; O'Gara F; Dobson AD; Morrissey JP
    J Microbiol Methods; 2012 Jan; 88(1):63-6. PubMed ID: 22056231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening strategies to identify HSP70 modulators to treat Alzheimer's disease.
    Repalli J; Meruelo D
    Drug Des Devel Ther; 2015; 9():321-31. PubMed ID: 25609918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel high-throughput cellular screening assay for the discovery of HIV-1 integrase inhibitors.
    Van Loock M; Meersseman G; Van Acker K; Van Den Eynde C; Jochmans D; Van Schoubroeck B; Dams G; Heyndrickx L; Clayton RF
    J Virol Methods; 2012 Feb; 179(2):396-401. PubMed ID: 22172974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of amide replacements that improve activity and metabolic stability of a bis-amide smoothened antagonist hit.
    Brown ML; Aaron W; Austin RJ; Chong A; Huang T; Jiang B; Kaizerman JA; Lee G; Lucas BS; McMinn DL; Orf J; Rong M; Toteva MM; Xu G; Ye Q; Zhong W; Degraffenreid MR; Wickramasinghe D; Powers JP; Hungate R; Johnson MG
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5206-9. PubMed ID: 21840217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of S-adenosyl-L-homocysteine hydrolase inhibitors based on non-adenosine analogs.
    Nakao A; Suzuki H; Ueno H; Iwasaki H; Setsuta T
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4336-40. PubMed ID: 25022879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel bacterial RNA polymerase inhibitors: pharmacophore-based virtual screening and hit optimization.
    Hinsberger S; Hüsecken K; Groh M; Negri M; Haupenthal J; Hartmann RW
    J Med Chem; 2013 Nov; 56(21):8332-8. PubMed ID: 24112046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Throughput Screening for the Discovery of Enzyme Inhibitors.
    Lloyd MD
    J Med Chem; 2020 Oct; 63(19):10742-10772. PubMed ID: 32432874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of novel isothiazole inhibitors of the TrkA kinase: structure-activity relationship, computer modeling, optimization, and identification of highly potent antagonists.
    Lippa B; Morris J; Corbett M; Kwan TA; Noe MC; Snow SL; Gant TG; Mangiaracina M; Coffey HA; Foster B; Knauth EA; Wessel MD
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3444-8. PubMed ID: 16632359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pain of high-throughput screening--pan assay interference compounds].
    Xie T; Du GH
    Yao Xue Xue Bao; 2015 Aug; 50(8):925-30. PubMed ID: 26668990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computer-aided discovery and biological characterization of human lactate dehydrogenase 5 inhibitors with anti-osteosarcoma activity.
    Cao W; Fang L; Teng S; Chen H; Wang Z
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2229-2233. PubMed ID: 29861142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.